Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
petemantx's Profile
Displaying 1001-1050 of 1704 result(s).
IPIX Innovation Pharmaceuticals Inc
04/03/2018 2:59:15 PM
That can't be right because: Say a
IPIX Innovation Pharmaceuticals Inc
04/03/2018 12:51:05 PM
They don't have to cover at any set (1)
IPIX Innovation Pharmaceuticals Inc
04/02/2018 7:11:21 PM
Just read an article where a man fr
IPIX Innovation Pharmaceuticals Inc
03/31/2018 3:50:30 PM
Good to know.
IPIX Innovation Pharmaceuticals Inc
03/31/2018 3:21:43 PM
Hadn't thought about it before, but
IPIX Innovation Pharmaceuticals Inc
03/29/2018 10:47:43 PM
IMO the results from the renal canc (1)
IPIX Innovation Pharmaceuticals Inc
03/29/2018 6:53:56 PM
I think the reformulations aren't g (1)
IPIX Innovation Pharmaceuticals Inc
03/27/2018 2:54:46 PM
Is that an indication that .515 is
IPIX Innovation Pharmaceuticals Inc
03/26/2018 3:39:46 PM
Another placebo question in that fa (1)
IPIX Innovation Pharmaceuticals Inc
03/26/2018 3:37:27 PM
I thought treatment ended late Nov (2)
IPIX Innovation Pharmaceuticals Inc
03/26/2018 3:28:57 PM
I think this failure of a competito (3)
IPIX Innovation Pharmaceuticals Inc
03/26/2018 2:37:24 PM
I understand the justification for
IPIX Innovation Pharmaceuticals Inc
03/26/2018 12:31:33 PM
i would have thought the vast major (2)
IPIX Innovation Pharmaceuticals Inc
03/26/2018 10:26:18 AM
I would say then that the CRO has d
IPIX Innovation Pharmaceuticals Inc
03/25/2018 11:45:15 PM
You can edit a post within 15 minut (1)
IPIX Innovation Pharmaceuticals Inc
03/25/2018 10:41:17 AM
Do companies running clinical trial
IPIX Innovation Pharmaceuticals Inc
03/23/2018 8:42:05 PM
I agree that there is no real marke (2)
IPIX Innovation Pharmaceuticals Inc
03/21/2018 4:54:52 PM
I have deep reservations about ffro (7)
IPIX Innovation Pharmaceuticals Inc
03/20/2018 9:35:10 PM
I greatly appreciate the time and e (5)
IPIX Innovation Pharmaceuticals Inc
03/20/2018 4:58:38 PM
At what point, if any, do the short
IPIX Innovation Pharmaceuticals Inc
03/20/2018 8:50:18 AM
They did not see fit to reinstall i
IPIX Innovation Pharmaceuticals Inc
03/20/2018 8:41:24 AM
Trying to get this restored on IHUB (12)
IPIX Innovation Pharmaceuticals Inc
03/15/2018 8:49:34 AM
It also states that P2B data not re (1)
IPIX Innovation Pharmaceuticals Inc
03/15/2018 8:34:15 AM
Your scenario would make IPIX billi (1)
IPIX Innovation Pharmaceuticals Inc
03/14/2018 8:18:34 PM
The correct answers are as follows:
IPIX Innovation Pharmaceuticals Inc
03/14/2018 8:11:05 PM
I posted about some things being ju
IPIX Innovation Pharmaceuticals Inc
03/14/2018 2:47:52 PM
Post I made on IHUB just now that w (5)
IPIX Innovation Pharmaceuticals Inc
03/13/2018 2:22:29 PM
Why wouldn't you prefer all stock t (2)
IPIX Innovation Pharmaceuticals Inc
03/12/2018 12:50:40 PM
Then I guess BP better pony up some
IPIX Innovation Pharmaceuticals Inc
03/12/2018 12:18:11 PM
Wouldn't the size of the target mar
IPIX Innovation Pharmaceuticals Inc
03/09/2018 1:14:41 PM
It seems to me like the only hope t (2)
IPIX Innovation Pharmaceuticals Inc
03/09/2018 10:04:41 AM
What could any mgt do on a regular
IPIX Innovation Pharmaceuticals Inc
03/08/2018 7:55:00 PM
hate to ask but at the end of your
IPIX Innovation Pharmaceuticals Inc
03/08/2018 1:47:16 PM
As I posted on IHUB, I am of the op (3)
IPIX Innovation Pharmaceuticals Inc
03/08/2018 1:23:36 PM
I knew it was the dang Northeasters (1)
IPIX Innovation Pharmaceuticals Inc
03/08/2018 9:43:45 AM
I am pleased beyond belief in the d (4)
IPIX Innovation Pharmaceuticals Inc
03/06/2018 11:51:32 AM
Would be wonderful to have a deal c (2)
IPIX Innovation Pharmaceuticals Inc
03/05/2018 7:50:32 PM
Cabel had posted that he was going (1)
IPIX Innovation Pharmaceuticals Inc
03/05/2018 7:35:07 PM
Post I just made on IHUB: (7)
IPIX Innovation Pharmaceuticals Inc
03/05/2018 6:32:18 PM
Isn't it nice to be in a biotech st (1)
IPIX Innovation Pharmaceuticals Inc
03/05/2018 6:26:56 PM
Sorry if i didn't make it clear tha
IPIX Innovation Pharmaceuticals Inc
03/05/2018 11:59:04 AM
Wonder if the post by cabel on IHUB
IPIX Innovation Pharmaceuticals Inc
03/05/2018 11:29:43 AM
I wrote the following posts to a se (6)
IPIX Innovation Pharmaceuticals Inc
03/05/2018 10:53:43 AM
I don't see any reason where the sh (4)
IPIX Innovation Pharmaceuticals Inc
03/05/2018 9:03:27 AM
Question while we wait patiently fo
IPIX Innovation Pharmaceuticals Inc
03/02/2018 2:55:05 PM
Below is the post I made on IHUB th (8)
IPIX Innovation Pharmaceuticals Inc
02/28/2018 9:18:05 PM
I agree w/ Incubus that both would (1)
IPIX Innovation Pharmaceuticals Inc
02/28/2018 8:41:54 PM
I know that we have Otezla beat han (5)
IPIX Innovation Pharmaceuticals Inc
02/28/2018 5:37:17 PM
makes sense, thanks. only asked as
IPIX Innovation Pharmaceuticals Inc
02/28/2018 4:19:27 PM
Once P gets approved for psoriasis,
Go to page:
  • << First
  • < Previous
  • 20
  • 21
  • Next >

Recent Articles

  • Altucher's Game-Changing Insights on Starlink's Next Moves
  • AHIP Announces Q2 2025 Results Call for Investors
  • Paladin Energy's Langer Heinrich Mine Operational Insights for FY2026
  • Paladin Energy Ltd Reports Positive Results for Recent Quarter
  • Adyton Resources Secures C$10 Million Through Private Placement
  • Bezos Makes Strategic Moves Amid SpaceX Challenges and Trump
  • Alto Neuroscience Faces Class Action Lawsuit - What to Know
  • Urgent Call for Reforms as Capacity Prices Soar Again
  • ACRE Secures $1 Billion Credit Fund for Multifamily Lending
  • Insights on IBM's Upcoming Earnings Report and Future Growth
  • Adyton Resources Secures C$10 Million for Growth Initiatives
  • BlackSky Technology Faces Stock Downturn Despite Analyst's Optimism
  • Alto Neuroscience Faces Class Action Lawsuit Over Misleading Claims
  • Larry Ellison's Defense of Elon Musk Highlights Bold Visionaries
  • Transforming a $100 Investment in AeroVironment Over 15 Years
  • Alphabet Inc: Navigating Challenges for Future Growth
  • McDonald's Declares Impressive Quarterly Cash Dividend
  • Gray Media Boosts Offering with $775 Million First Lien Notes
  • UnitedHealthcare Expands Heartflow Technology Access Nationwide
  • Investors of Broadmark Realty Capital Urged to Act on Legal Claims
  • GEBHARDT Intralogistics Sponsors Colombian Racer Óscar Tunjo
  • Significant Growth of Ulta Beauty Over 15 Years Explained
  • Krispy Kreme's Stock Surges Amidst Retail Trading Revival
  • Investors Can Take Advantage of Reckitt Benckiser Group Legal Suit
  • Westgold Resources Q4 FY25 Report: Strong Production and Growth
  • Investors' Class Action Lawsuit Against Neogen Corporation Explained
  • Micro Medical Solutions Elevates George Quinoy to CEO Role
  • Investors' Path to Justice in Reckitt Benckiser Fraud Case
  • Reckitt Benckiser Group PLC Faces Legal Actions from Investors
  • Douglas Dynamics Prepares for Second Quarter Earnings Call
  • Rate Field Honors Military Families with White Sox Tribute
  • Black Hills Corporation Updates Shareholders with Dividends
  • Domestic Metals Corp. Successfully Completes Financing Round
  • Broadwind Secures $6 Million Order for Precision Gearing
  • Examining the Growth of Casella Waste Systems Stock Over Two Decades
  • Pulse Seismic Inc. Delivers Impressive Financial Growth in 2025
  • Domestic Metals Corp. Successfully Closes First Tranche Offering
  • Evaluating Gen Digital's Current Market Performance Metrics
  • Western Energy Services Reports Q2 2025 Financial Highlights
  • OysterLink Highlights Rising Demand for Fair Wage Charges
  • Northwest University Welcomes New Leader to Inspire Change
  • Black Hills Corp. Declares Quarterly Dividend and Earnings Report
  • Broadwind Secures Major Order for Precision Gearing Solutions
  • Burke Products Partners with Datavault AI to Boost Defense Tech
  • Pulse Seismic Inc. Achieves Significant Growth in Financials
  • NN, Inc. Welcomes Tim Erro as Chief Commercial Officer
  • OFA Group Highlights Strategic Digital Asset Treasury Initiative
  • Douglas Dynamics' Upcoming Earnings Call Insights and Updates
  • Tim Erro Joins NN, Inc. as Chief Commercial Officer to Drive Growth
  • Investing in O'Reilly Automotive: A Five-Year Journey
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site